Comparative Effectiveness of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Preventing Alzheimer's Disease, Vascular Dementia, and Other Dementia Types Among Patients with Type 2 Diabetes

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 9117a96c4d0b9673-LAX IP: 116.62.10.13 UTC time: 2025-02-13T20:45:23+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4